Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of Venlafaxine Immediate-Release Suspensions

Author(s):  Donnelly Ronald F, Wong Keith, Goddard Rob, Johanson Christel

Issue:  Jan/Feb 2011 - Volume 15, Number 1
View All Articles in Issue

Page(s):  81-84

Note:  Electronic version includes errata or revisions.

Stability of Venlafaxine Immediate-Release Suspensions Page 1
Stability of Venlafaxine Immediate-Release Suspensions Page 2
Stability of Venlafaxine Immediate-Release Suspensions Page 3
Stability of Venlafaxine Immediate-Release Suspensions Page 4

Download in electronic PDF format for $75

Abstract:  Venlafaxine is a novel antidepressant that works by inhibiting the reuptake of serotonin and norepinephrine. The objectives of this study were to reformulate a venlafaxine extended-release suspension into an immediate-release preparation and then determine the physical and chemical stability of the new venlafaxine formulation. Suspensions of venlafaxine (75 mg/5mL) were prepared from extended-release microspheres that had been reduced to powder and then dispersed in either OraPlus/OraSweet (50:50) or simple syrup. Triplicate samples of the suspensions were collected from amber plastic bottles stored at either 5ºC or 23ºC on days 0, 7, 14, 21, and 28, and assayed. Physical stability was based on color and pH changes. A validated high-performance liquid chromatography assay method was used to determine the chemical stability of the active ingredient. This study found that venlafaxine immediate-release suspensions, prepared in either OraPlus/OraSweet or simple syrup, are physically and chemically stable for 28 days when stored in amber plastic bottles at either 5ºC or 23ºC.

Related Keywords: venlafaxine, antidepressant, immediate release suspension, stability, excipients

Related Categories: MENTAL HEALTH, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of Venlafaxine Immediate-Release Suspensions
Donnelly Ronald F
, Wong Keith, Goddard Rob, Johanson Christel
Jan/Feb 2011
Pg. 81-84

Erratum: Stability of Venlafaxine Immediate-Release Suspensions
Allen Loyd V Jr
Mar/Apr 2011
Pg. 175

Formulation Optimization Study for an Immediate-Release Tablet
Kyriacos Soula
, Dimassi Hani
May/Jun 2009
Pg. 259-261

Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
, Zhao Fang, Schweighardt Anne
Sep/Oct 2021
Pg. 364-371

Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid
, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017
Pg. 418-425

Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
May/Jun 2020
Pg. 233

Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S
, Thyangarajapuram N
Sep/Oct 2003
Pg. 389-393

Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
Jan/Feb 2013
Pg. 10-22

Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Bogner Robin H
, Szwejkowski Jessica, Houston Alana
Sep/Oct 2001
Pg. 401-405

Stability of Allopurinol Suspension Compounded from Tablets
Alexander Kenneth S
, Davar Nipun, Parker Gordon A
Mar/Apr 1997
Pg. 128-131

Venlafaxine 15 mg/mL in Syrup
Allen Loyd V Jr
Jan/Feb 2020
Pg. 63

Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji
, Sumanasekera Wasana, Le Uyen Minh
Jan/Feb 2022
Pg. 65-71

The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet
Alhmoud Hassan
, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Sep/Oct 2023
Pg. 431-439

In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A
, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
Sep/Oct 2013
Pg. 424-431

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2021
Pg. 431-439

Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila
, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Mar/Apr 2017
Pg. 160-163

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson
, Polonini Hudson
Jul/Aug 2022
Pg. 283-291

Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio
, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023
Pg. 72-77

Return to Top